VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Small Molecules and mAbs as Antiviral Therapy for COVID-19View Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIVView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Abstract - Driven Presentations IIView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Andrea Del Luca Lecture & Roundtable debateView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Abstract - Driven Presentations IView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic - Andreas Chrysostomou, MScView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Usefulness of Next-Generation Sequencing on PBMC Samples and HIV-1 DNA Quantification in Management of Treatment Optimization in HIV-1 Infected Virologically Suppressed Individuals - Daniele ArmeniaView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021APOBEC Editing in HIV DNA Proviral Vif and Pol Long-Reads Issued from Virologically-Suppressed Patients Included in the ANRS LAMIDOL Trial - Charlotte Charpentier, PharmD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Dynamics of Total and Intact HIV-1 DNA in in Virologically Suppressed Patients Switching to DTG+3TC or ATV/r+3TC Dual Therapy - Filippo Dragoni, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Exploration of the Possible Mechanisms Leading to Greater Mortality in People with Limited Drug Options (LDO) - Alessandro Cozzi-Lepri, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Determinants of HIV-1 Late Presentation in Patients Followed in Europe- Mafalda Miranda, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2021Exploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE Study - Margaret GartlandView Video
